RPSG VENTURES LIMITED (RPSGVENT)

Services · Commercial Services & Supplies · NSE · Updated 19 July 2026

₹895.3 ↓ 0.25% (1Y)

🎯 Key Takeaways

RPSG Ventures Limited is undergoing a strategic transformation, marked by significant acquisitions and restructuring activities, shifting focus from its core services business to healthcare through the integration of Clarionix Healthcare and Woodlands Multispeciality Hospital. The company is in a phase of active reinvestment and operational realignment, reflected in recent board approvals for major consolidation moves.
Revenue grew 10.1% QoQ to ₹2,385 in Q3FY25.
⚠️ 1) Integration risks from the complex healthcare consolidation, including regulatory delays and operational synergies yet to be realized. 2) Persisten

Market Cap

₹3,095

P/E Ratio

54.0

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About RPSGVENT 📊 Interactive Charts

📖 The Story

RPSG Ventures Limited is undergoing a strategic transformation, marked by significant acquisitions and restructuring activities, shifting focus from its core services business to healthcare through the integration of Clarionix Healthcare and Woodlands Multispeciality Hospital. The company is in a phase of active reinvestment and operational realignment, reflected in recent board approvals for major consolidation moves.

📰 What's Happening

In June 2026, the board approved the acquisition of Clarionix Healthcare Private Limited for INR 1 lakh and a composite scheme involving the amalgamation of Woodlands Multispeciality Hospital Limited into the company, followed by a slump sale of its hospital business to the newly acquired subsidiary for INR 400 crore. These moves, detailed in multiple filings including the June 25, 2026 board meeting notice and subsequent corporate action disclosure, are part of a broader restructuring initiative requiring NCLT and regulatory approvals. The company also increased its borrowing limit to ₹2,500 crore during the AGM on July 8, 2026, to support future capital needs.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Q4FY23	Q1FY24	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25
Revenue	1,792	2,296	1,789	1,846	2,020	2,516	2,166	2,385
Operating Profit	191	623	235	215	234	561	225	286
OPM %	10.0%	26.9%	11.8%	10.6%	11.2%	21.9%	10.1%	11.3%
Net Profit	-132	362	-15	-55	-95	271	-73	-46
EPS	₹-41.68	₹51.84	₹-11.72	₹-20.70	₹-32.60	₹30.79	₹-23.52	₹-18.13

The company's financial performance shows volatility, with a sharp decline in profitability from Q1FY25 to Q3FY25. Revenue peaked in Q1FY25 at ₹2,516 crore with a strong profit of ₹271 crore, but subsequent quarters reflect margin compression and rising losses, with Q3FY25 reporting a loss of ₹46 crore and negative EPS of ₹-18.13. This downturn coincides with operational transitions and integration challenges associated with its healthcare expansion, suggesting that recent financial results are being impacted by restructuring and investment phases rather than core business strength.

🔮 Management Outlook & What's Next

Management has not provided explicit forward guidance on profitability or revenue growth in the available filings. However, the strategic focus appears to be on long-term consolidation in the healthcare sector, as evidenced by the approved amalgamation and slump sale arrangements. The absence of dividend declarations and increased borrowing capacity suggest a capital allocation strategy prioritizing growth and restructuring over immediate returns to shareholders.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Commercial Services & Supplies

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
Redington Limited	17,300	13.7	—	—	—
Central Mine Planning & Design Institute Limited	16,603	—	—	—	—
Firstsource Solutions Limited	16,561	28.8	—	—	—
International Gemological Institute Limited	14,117	26.6	—	—	—
eClerx Services Limited	13,949	26.9	—	—	—
MMTC Limited	9,449	61.2	—	—	—
Nesco Limited	8,669	25.3	—	—	—
Inox Green Energy Services Limited	7,132	209.0	—	—	—
WeWork India Management Limited	6,808	—	—	—	—
Nirlon Limited	5,390	—	—	—	—

🔗 Peer Stock Analyses

REDINGTON CMPDI FSL IGIL ECLERX

⚠️ Risk Factors

1) Integration risks from the complex healthcare consolidation, including regulatory delays and operational synergies yet to be realized. 2) Persistent losses and margin compression in core services, which may pressure cash flows during the transition. 3) High leverage plans amid volatile profitability, increasing financial risk. 4) Execution dependency on NCLT and regulatory approvals for key restructuring schemes, which could delay or alter the strategic timeline.

📋 Recent Filings

🧠 Analyst's Read

RPSG Ventures is in a high-stakes transformation phase, betting on healthcare consolidation to drive future growth. Investors should monitor regulatory approvals, integration progress, and cash flow resilience as critical near-term catalysts. The company's trajectory hinges on whether the restructuring delivers sustainable profitability beyond the current loss-making phase.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on RPSGVENT

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-19.

📡 Get AI alerts when RPSGVENT files new disclosures

Track RPSGVENT filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track RPSGVENT — Free

Free account · 2 AI queries/day